Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment of the day

    Investment of the day

    Tencent-backed China online healthcare venture raises $250 million

    Tencent-backed China online healthcare venture raises $250 million

    Garima25 April 2019 11:07 AM IST
    BEIJING: China's Tencent Trusted Doctor, a venture backed by tech giant Tencent Holdings, said it has raised $250 million in a fundraising round, as...
    Everstone acquires stake in Chennai based CPC Diagnostics

    Everstone acquires stake in Chennai based CPC Diagnostics

    Garima14 March 2019 4:59 PM IST
    The strategic partnership with Everstone Group will help CPC Diagnostics take its product portfolio to new customers and markets, the Chennai-based...
    Cipla to acquire 11.71 percent stake in Wellthy Therapeutics

    Cipla to acquire 11.71 percent stake in Wellthy Therapeutics

    Garima20 Feb 2019 2:55 PM IST
    New Delhi: Drug major Cipla Monday said it has inked a pact to acquire 11.71 per cent stake in Wellthy Therapeutics. Golden cross Pharma, a...
    InvAscent-led India Life Sciences Fund raises Rs 25 crore for its New Fund

    InvAscent-led India Life Sciences Fund raises Rs 25 crore for its New Fund

    Garima2 Feb 2019 4:16 PM IST
    InvAscent, famed for its early-stage backing of Gland Pharma and Health Care Global through the first fund Evolvence India Life Sciences Fund, will...
    Eli Lilly to acquire Loxo Oncology for $8 billion

    Eli Lilly to acquire Loxo Oncology for $8 billion

    Medical Dialogues Bureau8 Jan 2019 12:09 PM IST
    Washington: -Pharmaceutical giant Eli Lilly will acquire cancer treatment specialist Loxo Oncology in a cash deal valued at around $8 billion, the...
    Strides Pharma board approves USD 15 million investment in Stelis Biopharma

    Strides Pharma board approves USD 15 million investment in Stelis Biopharma

    Medical Dialogues Bureau23 Nov 2018 12:14 PM IST
    New Delhi: Strides Pharma Science Thursday said its board has approved plans to invest another USD 15 million in its biotech arm Stelis Biopharma. The...
    Make in Odisha:  government launches Rs 2750 Crore investment in Healthcare

    Make in Odisha: government launches Rs 2750 Crore investment in Healthcare

    Medical Dialogues Bureau16 Nov 2018 10:00 AM IST
    New Delhi: Odisha government has launched the Vision-2025 health care at the Make in Odisha Conclave 2018, the flagship biennial global investors'...
    Strides Pharma Science to get Rs 147 Crore funding for consumer healthcare business

    Strides Pharma Science to get Rs 147 Crore funding for consumer healthcare business

    Medical Dialogues Bureau2 Nov 2018 11:57 AM IST
    The agreement also envisages Strides Consumer Pvt Ltd to become a fully owned subsidiary of Strides Global Consumer Healthcare Ltd at a later date,...
    BRS Venture Plans to invest Rs 2193 crore to acquire Indian Hospitals

    BRS Venture Plans to invest Rs 2193 crore to acquire Indian Hospitals

    Medical Dialogues Bureau28 Oct 2018 9:15 AM IST
    New Delhi: The UAE-based USD 3 billion BRS Ventures plans to acquire hospitals in India, as it looks to consolidate its healthcare practice. BRS...
    China fines pharma firm $1.3 billion in vaccine scandal

    China fines pharma firm $1.3 billion in vaccine scandal

    Medical Dialogues Bureau17 Oct 2018 3:03 PM IST
    BEIJING: Chinese authorities have slapped penalties totaling a whopping US$1.3 billion on a pharmaceutical company over a vaccine scandal that fuelled...
    Abraajs stake in 1 Billion Dollar healthcare fund to be split among other investors

    Abraajs stake in 1 Billion Dollar healthcare fund to be split among other investors

    Medical Dialogues Bureau10 Oct 2018 6:04 PM IST
    Lenders, which had been expecting AlixPartners to sell Abraaj’s stake in the fund to other partners or dilute the stake, view the move as the worst...
    Trivitron Healthcare eyes Rs 750 crore revenue in Financial Year 2019

    Trivitron Healthcare eyes Rs 750 crore revenue in Financial Year 2019

    Medical Dialogues Bureau8 Oct 2018 10:25 AM IST
    New Delhi: Domestic medical devices maker Trivitron Healthcare is looking to clock revenue of around Rs 750 crore in the current fiscal year, as it...
    Next

    Popular Stories

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral...

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok